Pathalys Raises $105m To Pave Path Toward US Commercialization

Series B Follows $150m Series A In January 2023

Stairway to money success, financial independent or financial freedom, income growth or wealth management or investment opportunity concept
Pathalys raised money for next steps: completing Phase III, filing for approval and commercialization • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business